Curis | CRIS - Ebitda





Ebitda Cambiamento Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 10.29B 1.86B 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06